The crude ethanolic extract of Nauclea latifolia yielded five known compounds, strictosamide (1), naucleamides A (2), naucleamide F (3), quinovic acid-3-O-β-rhamnosylpyranoside (4), and quinovic acid 3-O-β-fucosylpyranoside (5). Microbial reactions, using a whole cell culture of Rhizopus circinans on compound (1), yielded three analogues, 10-hydroxystrictosamide (6), 10-β-glucosyloxyvincoside lactam (7) and 16,17-dihydro-10-β-glucosyloxyvincoside lactam (8). Compounds 1-8 were identified with the aid of extensive NMR spectral studies. Compound 8 was found to be a new metabolite. Compounds 1-8 exhibited different levels of anti-GST and anti-fungal activities.
Nauclea latifolia S.M. (Rubiaceae) is a medicinally important plant predominantly distributed in the tropical regions of sub-Sahara Africa. Its roots and stem have been medicinally used as a chewing stick in the eastern and northern parts of Nigeria [1] . The ethanolic extract of roots and stem have been reported to exhibit in vitro anti-plasmodial activity against chloroquine-sensitive and chloroquineresistant Nigerian and FCB1-Colombia strains of Plasmodium falciparum (IC 50 = 0.6-7.5 μg/mL) [2, 3] . This extract has also shown in vivo anthelminthic activity against a mixture of nematode species, as well as antibacterial and antifungal activities against pathogenic bacteria and fungi [4] .
We are involved in discovering natural products exhibiting glutathione S-transferase and acetylcholinesterase inhibitory activities [5] [6] [7] . In our continuing effort in this area, we discovered the GST inhibitory activity of the crude ethanolic extract of N. latifolia, with an IC 50 value of 10.5 μg/mL. Our GST inhibition-directed phytochemical studies on this extract resulted in the isolation of five known bioactive natural products, strictosamide (1), naucleamide A (2), naucleamide F (3), quinovic acid-3-O-β-rhamnosylpyranoside (4), and quinovic acid 3-O-β-fucosylpyranoside (5) . Compounds 1-5 were identified by comparing their UV, IR, mass, 1 H-and 13 C-NMR spectral data with those reported in the literature [8] [9] [10] [11] [12] .
Compound 1 was isolated in large quantity and was subjected to microbial reactions using whole fungal cell cultures. To achieve this goal, we screened five different fungi, namely Mucor plumbeus (ATCC 4740), Cunninghamella blakesleeana (ATCC 9245), C. echinulata (ATCC 9244), Curvularia lunata (ATCC 12017), Rhizopus circinans (ATCC 1225) and Aspergillus niger (ATCC 1004), for their capability to metabolize compound 1. During these biotransformation experiments, we discovered that R. circinans metabolized compound 1 into 10-hydroxystrictosamide (6), 10-β-glucosyloxyvincoside lactam (7) and 16,17-dihydro-10-β-glucosyloxyvincoside lactam (8) . Compounds 6 and 7 were known metabolites as their UV, IR, mass, 1 H-and 13 spectral data matched nicely with those of 10hydroxystrictosamide and 10-β-glucosyloxyvincoside lactam, reported in the literature [13] [14] [15] . Compound 8 was found to be a new metabolite.
16,17-Dihydro-10-β-glucosyloxyvincoside lactam (8) was isolated as a yellow colored gum from the fermentation flask of R. circinans. A combination of 13 C NMR and HR-FAB-MS data of 8 provided its molecular formula as C 32 H 42 N 2 O 14 (calcd 678.2636, found 678.2630). The UV and IR spectra of 8 were similar to those of compounds 6 and 7 [13] [14] [15] , indicating the presence of the same chromophore and functional groups in 8. Table 1 .
These spectral studies suggested that compound 8 was a 16,17 dihydro derivative of compound 7. The MS of 8 also showed fragments and losses expected for the 16,17-dihydro derivative of 7. The NOESY Chemical constituents of Nauclea latifolia Natural Product Communications Vol. 4 (9) 2009 1187 spectrum of 8 suggested an α-orientation of H-16, as this proton exhibited an NOE with H-3. The stereochemistry at all other chiral centers in 8 was found to be the same as those in compound 1. Based on these spectral data, structure 8 was proposed for this new metabolite.
A time-dependent biotransformation experiment was also performed in order to determine the sequence for the formation of metabolites 6-8. This experiment was carried out by incubating compound 6 in the liquid culture of R. circinans; this afforded compounds 7 and 8. We incubated compound 7 in the fermentation flask of this fungus and this yielded compound 8. These studies suggested that R. circinans initially performed microbial hydroxylation at C-10 of compound 1 to yield compound 6. This metabolite further underwent glycosylation, followed by reduction of the Δ 16-17 double bond to give compounds 7 and 8, respectively.
Biological activities:
Compounds 1-8 exhibited a wide range of anti-GST activities [16] and these data are listed in Table 2 . It was found that compounds 1, and 6-8 were significantly active in our GST inhibition assays, with IC 50 values of 20.5, 18.6, 12.3 and 16.6 μM, respectively. These bioactivity data indicated that anti-GST activities of compounds 1, 6-8 were more or less comparable with ethacrynic acid (IC 50 = 16.9), a standard GST inhibitor.
Compounds 1-8 were also screened for antifungal activity [17] against Candida albicans and these compounds were found to be moderately active in this assay with minimum inhibitory concentrations in the range of 16-32 μg/mL. In summary, we have identified compounds 1-5 from the bioactive fraction of N. latifolia exhibiting different levels of GST inhibitory activities. The bioactivity data for the natural products (1-5)
indicated that the indole alkaloid, strictosamide (1) showed the best GST inhibitory activity. Microbial reactions on compound 1 suggested that by the introduction of either an hydroxyl or sugar moiety at C-10 increases the anti-GST properties of compounds 6-8. Furthermore, the anti-GST activity data also indicated that the double bond at Δ 16-17 in compounds 1, and 6-8 might not play a significant role in this bioactivity. It was also discovered that R. circinans regiospecifically reduced the double bond at Δ [16] [17] .
Further biotransformation experiments on different related compounds are warranted in order to determine the applicability of this microbial reaction in organic synthesis. 
Experimental

Microbial reactions on compound 1:
Microbial reactions on compound 1, using a whole cell culture of R. circinans, was performed using a standard twostage microbial transformation method [18, 19] . The crude n-butanolic extracts obtained from the liquid culture of R. circinans were subjected to reversephase HPLC using a gradient elution of methanolwater (0-40) to afford 6 (50 mg, 38.5% yield), 7 (12 mg, 9.2 % yield), and 8 (6 mg, 4.6% yield).
16,17-Dihydro-10-β-glucosyloxyvincoside lactam (8) [α] D : -110 (c 0.20, MeOH). 
